Atomoxetine: A New Therapeutic Option for the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
Montoya, Alonso
机构：
来源：
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2008年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [31] A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder
    Kratochvil, Christopher J.
    Vaughan, Brigette S.
    Mayfield-Jorgensen, Michelle L.
    March, John S.
    Kollins, Scott H.
    Murray, Desiree W.
    Ravi, Hima
    Greenhill, Laurence L.
    Kotler, Lisa A.
    Paykina, Natalya
    Biggins, Patricia
    Stoner, Julie
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (02) : 175 - 185
  • [32] MONITORING ATOMOXETINE CONCENTRATIONS IN HAIR IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Papaseit, E.
    Marchei, E.
    Mortali, C.
    Aznar, G.
    Garcia-Algar, O.
    Pacifici, R.
    Pichini, S.
    Farre, M.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 43 - 43
  • [33] Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
    Ruppert, Katrin
    Geffert, Christoph
    Clement, Hans-Willi
    Bachmann, Christian
    Haberhausen, Michael
    Schulz, Eberhard
    Fleischhaker, Christian
    Biscaldi-Schaefer, Monica
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (07) : 945 - 959
  • [34] Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
    Katrin Ruppert
    Christoph Geffert
    Hans-Willi Clement
    Christian Bachmann
    Michael Haberhausen
    Eberhard Schulz
    Christian Fleischhaker
    Monica Biscaldi-Schäfer
    [J]. Journal of Neural Transmission, 2022, 129 : 945 - 959
  • [35] Acute atomoxetine effects on the EEG of children with Attention-Deficit/Hyperactivity Disorder
    Barry, Robert J.
    Clarke, Adam R.
    Hajos, Mihaly
    McCarthy, Rory
    Selikowitz, Mark
    Bruggemann, Jason M.
    [J]. NEUROPHARMACOLOGY, 2009, 57 (7-8) : 702 - 707
  • [36] Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder
    Mark E. Bangs
    Ling Jin
    Shuyu Zhang
    Durisala Desaiah
    Albert J. Allen
    Holly A. Read
    Arie Regev
    Joachim F. Wernicke
    [J]. Drug Safety, 2008, 31 : 345 - 354
  • [37] Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children
    Zavadenko, N. N.
    Suvorinova, N. Yu.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2008, 108 (07) : 43 - 47
  • [38] Atomoxetine:: a new treatment for attention deficit/hyperactivity disorder (ADHD) in children and adolescents
    Purper-Ouakil, D
    Fourneret, P
    Wohl, M
    Rénéric, JP
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (03): : 337 - 348
  • [39] Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder
    Simpson, D
    Plosker, GL
    [J]. CNS DRUGS, 2004, 18 (06) : 397 - 401
  • [40] Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder
    Bangs, Mark E.
    Jin, Ling
    Zhang, Shuyu
    Desaiah, Durisala
    Allen, Albert J.
    Read, Holly A.
    Regev, Arie
    Wernicke, Joachim F.
    [J]. DRUG SAFETY, 2008, 31 (04) : 345 - 354
12345